Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cirrhosis, Liver
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Care Provider)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 45 years and 65 years
- Gender
- Both males and females
Description
Effect of use of propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy, Randomised controlled trial.
Effect of use of propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy, Randomised controlled trial.
Tracking Information
- NCT #
- NCT03388151
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sherief Abd-Elsalam, MD Gastroenterology Study Director: Sameh Abdelkhalek Ahmed, MD Tanta University Anasthesia Department
Get Well Soon